1. Home
  2. FUBO vs IKT Comparison

FUBO vs IKT Comparison

Compare FUBO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo fuboTV Inc.

FUBO

fuboTV Inc.

HOLD

Current Price

$11.53

Market Cap

284.3M

Sector

Industrials

ML Signal

HOLD

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.87

Market Cap

240.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUBO
IKT
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.3M
240.1M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FUBO
IKT
Price
$11.53
$1.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$28.40
$5.00
AVG Volume (30 Days)
2.4M
1.1M
Earning Date
05-06-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
48.08
57.76
EPS
N/A
N/A
Revenue
$4,271,000.00
N/A
Revenue This Year
$44.64
N/A
Revenue Next Year
$5.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10317.07
N/A
52 Week Low
$1.02
$1.33
52 Week High
$14.54
$2.37

Technical Indicators

Market Signals
Indicator
FUBO
IKT
Relative Strength Index (RSI) 59.73 55.52
Support Level $3.17 $1.43
Resistance Level $14.05 $1.88
Average True Range (ATR) 0.95 0.12
MACD -0.41 0.02
Stochastic Oscillator 15.32 78.12

Price Performance

Historical Comparison
FUBO
IKT

About FUBO fuboTV Inc.

FuboTV Inc is a sports-first, live TV streaming company offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, FuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. It offers subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality suited to their preferences. The company has one operating segment, the streaming business. Geographically, the company generates a majority of its revenue from the United States and also has a presence in other markets.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: